124 related articles for article (PubMed ID: 10439523)
41. Mycophenolate mofetil as a systemic antipsoriatic agent: positive experience in 11 patients.
Geilen CC; Arnold M; Orfanos CE
Br J Dermatol; 2001 Mar; 144(3):583-6. PubMed ID: 11260019
[TBL] [Abstract][Full Text] [Related]
42. Successful treatment of steroid-resistant minimal change disease with mycophenolate mofetil.
Mogyorósi A; Lippman HR; Feldman GM
Am J Nephrol; 2002; 22(5-6):569-72. PubMed ID: 12381961
[TBL] [Abstract][Full Text] [Related]
43. Case reports: nodular vasculitis responsive to mycophenolate mofetil.
Taverna JA; Radfar A; Pentland A; Poggioli G; Demierre MF
J Drugs Dermatol; 2006; 5(10):992-3. PubMed ID: 17373149
[TBL] [Abstract][Full Text] [Related]
44. Efficacy of mycophenolate mofetil in pediatric patients with steroid-dependent nephrotic syndrome.
Novak I; Frank R; Vento S; Vergara M; Gauthier B; Trachtman H
Pediatr Nephrol; 2005 Sep; 20(9):1265-8. PubMed ID: 15942779
[TBL] [Abstract][Full Text] [Related]
45. Induction therapy for active lupus nephritis: mycophenolate mofetil versus cyclophosphamide.
Burchardi C; Schlöndorff D
Nat Clin Pract Nephrol; 2006 Jun; 2(6):314-5. PubMed ID: 16932452
[No Abstract] [Full Text] [Related]
46. Immunosuppressive activity of mycophenolate mofetil.
Eugui EM; Allison AC
Ann N Y Acad Sci; 1993 Jun; 685():309-29. PubMed ID: 8363235
[No Abstract] [Full Text] [Related]
47. Histological changes after the use of mycophenolate mofetil in autoimmune hepatitis.
Brunt EM; Di Bisceglie AM
Hum Pathol; 2004 Apr; 35(4):509-12. PubMed ID: 15116334
[TBL] [Abstract][Full Text] [Related]
48. The muddle of mycophenolate mofetil in myasthenia.
Benatar M; Rowland LP
Neurology; 2008 Aug; 71(6):390-1. PubMed ID: 18678821
[No Abstract] [Full Text] [Related]
49. Double trouble: therapeutic challenges in patients with both juvenile dermatomyositis and psoriasis.
Kim NN; Lio PA; Morgan GA; Jarvis JN; Pachman LM
Arch Dermatol; 2011 Jul; 147(7):831-5. PubMed ID: 21422326
[TBL] [Abstract][Full Text] [Related]
50. Current and future oral systemic therapies for psoriasis.
Kelly JB; Foley P; Strober BE
Dermatol Clin; 2015 Jan; 33(1):91-109. PubMed ID: 25412786
[TBL] [Abstract][Full Text] [Related]
51. Mycophenolate mofetil for transplantation: new drug, old problems?
Gray DW
Lancet; 1995 Aug; 346(8972):390. PubMed ID: 7623565
[No Abstract] [Full Text] [Related]
52. Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory to standard therapy.
Devlin SM; Swain MG; Urbanski SJ; Burak KW
Can J Gastroenterol; 2004 May; 18(5):321-6. PubMed ID: 15152283
[TBL] [Abstract][Full Text] [Related]
53. Effect of mycophenolate mofetil therapy on inosine monophosphate dehydrogenase induction in red blood cells of heart transplant recipients.
Weigel G; Griesmacher A; Zuckermann AO; Laufer G; Mueller MM
Clin Pharmacol Ther; 2001 Mar; 69(3):137-44. PubMed ID: 11240978
[TBL] [Abstract][Full Text] [Related]
54. Induction of inosine monophosphate dehydrogenase activity after long-term treatment with mycophenolate mofetil.
Sanquer S; Breil M; Baron C; Dhamane D; Astier A; Lang P
Clin Pharmacol Ther; 1999 Jun; 65(6):640-8. PubMed ID: 10391669
[TBL] [Abstract][Full Text] [Related]
55. Successful therapy for bullous pemphigoid with mycophenolate mofetil.
Nousari HC; Griffin WA; Anhalt GJ
J Am Acad Dermatol; 1998 Sep; 39(3):497-8. PubMed ID: 9738791
[No Abstract] [Full Text] [Related]
56. Enteric-coated mycophenolate sodium in psoriasis vulgaris: an open pilot study.
Fallah Arani S; Waalboer Spuij R; Nijsten T; Neumann HA; Thio B
J Dermatolog Treat; 2014 Feb; 25(1):46-9. PubMed ID: 22998609
[TBL] [Abstract][Full Text] [Related]
57. Successful treatment of resistant hypertrophic and bullous lichen planus with mycophenolate mofetil.
Nousari HC; Goyal S; Anhalt GJ
Arch Dermatol; 1999 Nov; 135(11):1420-1. PubMed ID: 10566854
[No Abstract] [Full Text] [Related]
58. Triple therapy with mycophenolate mofetil, cyclosporine, and prednisone in renal transplantation.
Crespo JF; Górriz JL; Sancho A; Avila A; Alcoy E; Pallardó LM
Transplant Proc; 1999 Sep; 31(6):2261-2. PubMed ID: 10500568
[No Abstract] [Full Text] [Related]
59. Sequential therapies for proliferative lupus nephritis.
Contreras G; Pardo V; Leclercq B; Lenz O; Tozman E; O'Nan P; Roth D
N Engl J Med; 2004 Mar; 350(10):971-80. PubMed ID: 14999109
[TBL] [Abstract][Full Text] [Related]
60. Trough blood concentrations in long-term treatment with mycophenolate mofetil.
Sanquer S; Breil M; Baron C; Dahmane D; Astier A; Lang P
Lancet; 1998 May; 351(9115):1557. PubMed ID: 10326544
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
